Craft

Cardinal Health

Stock Price

$110.1

2024-10-29

Market Capitalization

$26.7 B

2024-08-26

Revenue

$222.6 B

FY, 2025

Cardinal Health Summary

Company Summary

Overview
Cardinal Health is a provider of healthcare services and products for healthcare facilities. It operates in two segments: Pharmaceutical and Specialty Solutions and Global Medical Products and Distribution (GMPD). The Pharmaceutical and Specialty Solutions segment distributes branded, generic, and specialty pharmaceuticals, over-the-counter healthcare and consumer products; operates nuclear pharmacies and manufacturing facilities; offers pharmacy management services, consulting, patient support, etc. The Global Medical Products and Distribution segment manufactures, sources, and distributes medical, surgical, and laboratory products and delivers supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers.
Type
Public
Status
Active
Founded
1971
HQ
Dublin, OH, US | view all locations
Website
https://www.cardinalhealth.com/
Cybersecurity rating
ESG rating
50-59 out of 100|View all ESG data
Sectors

Key People

  • Jason M. Hollar

    Jason M. Hollar, Chief Executive Officer, Director, Chief Executive Officer

  • Robert W. Azelby
  • Steve Mason

    Steve Mason, Chief Executive Officer, Medical Segment

  • Jessica L. Mayer

    Jessica L. Mayer, Chief Legal and Compliance Officer

Operating MetricsView all

Pharmacies Served

60K

Oct, 2023

Laboratories Served

6.5K

Feb, 2021

Patients

3.4M

Oct, 2023

LocationsView all

710 locations detected

  • Dublin, OH HQ

    United States

    7000 Cardinal Pl

  • Abilene, TX

    United States

    1900 Pine St

  • Abilene, TX

    United States

    3402 S 14th St

  • Albany, NY

    United States

    Village of Colonie

  • Albuquerque, NM

    United States

    235 Elm St NE

  • Albuquerque, NM

    United States

    4376 Alexander Blvd NE #8

and 704 others

Cardinal Health Financials

Summary Financials

Revenue (Q3, 2026)
$60.9B
Gross profit (Q3, 2026)
$2.5B
Net income (Q3, 2026)
$380.0M
Cash (Q3, 2026)
$3.9B
EBIT (Q3, 2026)
$509.0M

Footer menu